A new role for the virtual crossmatch in kidney allograft reuse.
Bryan
Christopher F
CF
Abdulkarim
Bashar
B
Forster
Jameson
J
Nelson
Paul W
PW
Diederich
Dennis
D
Murillo
Daniel
D
Markham
Lori
L
D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000009:adverse effects; D016031:Liver Transplantation / Q000009:adverse effects; D008875:Middle Aged; D012086:Reoperation; D014019:Tissue Donors / Q000600:supply & distribution*; D016896:Treatment Outcome
D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007518:Isoantibodies